Deciding about (neo-)adjuvant rectal and breast cancer treatment: Missed opportunities for shared decision making.

CONCLUSION: This study suggests that oncologists rarely express that a treatment decision needs to be made in consultations concerning preference-sensitive treatment decisions. Therefore, patients might not realize that foregoing (neo-)adjuvant treatment is a viable choice. Oncologists miss a crucial opportunity to facilitate SDM. PMID: 26237738 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26237738?dopt=Abstract

Source: Acta Oncologica - August 3, 2015 Category: Cancer & Oncology Authors: Kunneman M, Engelhardt EG, Ten Hove FL, Marijnen CA, Portielje JE, Smets EM, de Haes HJ, Stiggelbout AM, Pieterse AH Tags: Acta Oncol Source Type: research